// App-Quantinova.ai

THU0359 : ANTI-B2GLYCOPROTEIN-1 IGA ANTIBODIES INDEPENDENTLY AND DIFFERENTIALLY CONTRIBUTE TO THROMBOTIC RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS ABOVE AND BEYOND ACL AND LA: LESSONS FROM A CONTEMPORARY MULTIETHNIC PATIENT COHORT

Researchers

Presenter

  • T. Aung

Principal Investigators

  • G. Miller

  • S. Ormseth

  • R. Moran

  • G. Karpouzas

Medical Centers

  • Harbor UCLA Medical Center, Torrance, California, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Nephrotic syndrome

  • Hypertension

  • Venous thrombosis

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved